The effect of weight loss and inappropriate plasma dexamethasone levels on the DST.
Recent studies from different research groups have raised fundamental questions about the postulated specificity of the dexamethasone suppression test (DST) for endogenous depression. Findings in 116 psychiatric inpatients and 24 semi-starved healthy volunteers underline the importance of weight loss as a factor affecting DST results. A study of 160 DSTs in 93 psychiatric inpatients further revealed a significant negative correlation of plasma cortisol and plasma dexamethasone levels 10 hours after oral administration of 1 mg of dexamethasone. These results suggest a decisive effect of the pharmacokinetics of dexamethasone, at least on the 1-mg DST.
D000293:Adolescent; D000328:Adult; D001835:Body Weight; D003866:Depressive Disorder / Q000378:metabolism; D003907:Dexamethasone / Q000097:blood / Q000378:metabolism*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007700:Kinetics; D008297:Male; D001523:Mental Disorders / Q000378:metabolism*
D003907:Dexamethasone; D006854:Hydrocortisone